World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
58163
World Ranking
6915
National Ranking
210

Overview

Benjamin Besse is affiliated with the University of Paris-Saclay in France and has a research focus primarily within the field of medicine, with significant contributions in oncology, pulmonary and respiratory medicine, and cancer research. Their scholarly work spans related subfields including molecular biology and radiology, nuclear medicine, and imaging.

The scientist has authored numerous publications centered on lung cancer treatments and mutations, cancer immunotherapy and biomarkers, cancer genomics and diagnostics, and lung cancer research studies. Additional areas of expertise include lung cancer diagnosis and treatment, colorectal cancer treatments and studies, and the application of radiomics and machine learning in medical imaging.

Frequent publication venues for Benjamin Besse include:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Cancer Research
  • European Journal of Cancer

Among the notable recent papers are:

  • Sotorasib for Lung Cancers with KRAS p.G12C Mutation, 2021, New England Journal of Medicine
  • Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer, 2020, New England Journal of Medicine
  • Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial, 2022, The Lancet Oncology
  • Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer, 2022, Nature Medicine
  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology

Benjamin Besse has collaborated extensively with several co-authors, with multiple joint publications with David Planchard, Fabrice Barlési, Mihaela Aldea, Laura Mezquita, and Jordi Remón.

Best Publications

  • Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

    Alice T. Shaw;Dong Wan Kim;Kazuhiko Nakagawa;Takashi Seto

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

    Robert C Doebele;Alexander Drilon;Alexander Drilon;Luis Paz-Ares;Salvatore Siena

  • Sotorasib for Lung Cancers with KRAS p.G12C Mutation.

    Ferdinandos Skoulidis;Bob T. Li;Grace K. Dy;Timothy J. Price

  • Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

    David Planchard;Egbert F Smit;Harry J M Groen;Julien Mazieres

  • Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

    J. Mazieres;A. Drilon;A. Lusque;L. Mhanna

  • Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

    Fabrice Barlesi;Julien Mazieres;Jean-Philippe Merlio;Didier Debieuvre

  • Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.

    Laura Mezquita;Edouard Auclin;Roberto Ferrara;Melinda Charrier

  • Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

    Kathryn C. Arbour;Laura Mezquita;Niamh Long;Hira Rizvi

  • An open-label phase 2 trial of dabrafenib plus trametinib in patients with previously treated BRAF V600E–mutant metastatic non-small cell lung cancer

    David Planchard;Benjamin Besse;Harry J M Groen;Pierre-Jean Souquet

  • Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

    Benjamin Besse;Mélinda Charrier;Valérie Lapierre;Eric Dansin

  • Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

    Benjamin J. Solomon;Benjamin Besse;Benjamin Besse;Todd M. Bauer;Enriqueta Felip

  • Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

    Julien Mazières;Solange Peters;Benoit Lepage;Alexis B. Cortot

  • Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

    Roberto Ferrara;Laura Mezquita;Matthieu Texier;Jihene Lahmar

  • Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer

    Alexander Drilon;Geoffrey R. Oxnard;Daniel S.W. Tan;Herbert H.F. Loong

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial.

    Alice T Shaw;Enriqueta Felip;Todd M Bauer;Benjamin Besse;Benjamin Besse

  • CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients

    Fayçal Djenidi;Fayçal Djenidi;Fayçal Djenidi;Julien Adam;Julien Adam;Aïcha Goubar;Aïcha Goubar;Aurélie Durgeau;Aurélie Durgeau;Aurélie Durgeau

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor:Results of a Phase II Trial in Patients With Advanced Non-Small-Cell Lung Cancer

    Lecia V. Sequist;Benjamin Besse;Thomas J. Lynch;Vincent A. Miller

Frequent Co-Authors

David Planchard
David Planchard Institut Gustave Roussy
Jean-Charles Soria
Jean-Charles Soria Amgen (United States)
Julien Mazieres
Julien Mazieres Paul Sabatier University
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy
Nicolas Girard
Nicolas Girard Institute Curie
Fabrice Andre
Fabrice Andre Institut Gustave Roussy
Silvia Novello
Silvia Novello University of Turin
Nathalie Chaput
Nathalie Chaput Institut Gustave Roussy
Alice T. Shaw
Alice T. Shaw Harvard University
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens up various alternative and related career options, especially for those considering flexible or online education paths. For example, adn nursing programs are popular choices for students who want to start working as registered nurses more quickly. These programs often take less time than a traditional bachelor’s degree, making nursing more accessible to many.

If you’re interested in the administrative or coding side of healthcare, medical billing and coding schools online offer accredited programs that can lead to rewarding roles in hospitals, clinics, and insurance companies. These online options can often be pursued while working or fulfilling other responsibilities.

Not all nursing programs require the TEAS or HESI entrance exams. Learn more about do you have to take the teas test to get into nursing school and find options that align with your strengths and background.

For those interested in leadership roles, an online healthcare administration degree can provide the skills needed to manage healthcare teams and organizations. Online learning pathways make it easier than ever to advance your healthcare career, whatever your starting point.

Best Scientists Citing Benjamin Besse

Trending Scientists

Recently Published Articles